Navigation Links
Welvista Announces Partnering with sanofi-aventis U.S. to Provide Medication at No Cost to the Uninsured
Date:12/1/2008

COLUMBIA, S.C., Dec. 1 /PRNewswire/ -- Welvista is pleased to announce it has reached an agreement with sanofi-aventis U.S., one of the world's leading pharmaceutical companies, to dispense the company's medications to the uninsured through Welvista's no-cost prescription medication program. With the addition of 23 sanofi-aventis drugs from the company's Patient Assistance Programs (PAPs), Welvista now has 180 drugs on its formulary for the uninsured. Including sanofi-aventis, Welvista now partners with 12 pharmaceutical companies, making it the largest mail-order pharmacy for the uninsured in the country.

Welvista provides an innovative prescription drug program for residents in three states who fall below 200 percent of the federal poverty level and are without health insurance coverage. The William E. Murray pharmacy, located at Welvista's headquarters off Forest Drive in Columbia, dispensed more than $34 million dollars in prescription medications in 2007 to Welvista's patients to treat diabetes, hypertension, mental illness and more.

Welvista also provides oral healthcare services for the children of limited income families in South Carolina through Smiles for a Lifetime, with centers in Allendale County, Dillon II, Clarendon I and II school districts, and Charleston.

"Our pharmaceutical partners are essential to the success of our organization; we wouldn't exist without them," says Welvista CEO Ken Trogdon. "We are committed to improving health and wellness for the uninsured. Our model has proven its viability, and we will continue to add prescription drugs that we know our patients need."

About Welvista

Welvista is an innovative model of non-governmental healthcare intervention serving thousands of patients in three states. This healthcare network provides medications at no cost to the uninsured who do not qualify for Medicaid, Medicare or VA insurance and for those who cannot afford to pay for insurance coverage on their own. Welvista also operates Smiles, five pediatric dental care centers caring for approximately 5,000 children from limited income families who would not otherwise have access to oral healthcare. With the addition of sanofi-aventis U.S., Welvista now partners with 12 pharmaceutical companies that donate prescription drugs to approved patients. To learn more about the organization, visit www.welvista.org.

About sanofi-aventis U.S.

Sanofi-aventis U.S. is an affiliate of sanofi-aventis, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT:SAN) and in New York (NYSE: SNY). For more information, visit: www.sanofi-aventis.us or www.Sanofi-aventis.com.


'/>"/>
SOURCE Welvista
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Michael and ... Dana Farber Cancer Institute. For Betsy, the clinical trial has been life-saving as ... has not worsened. , Betsy Brauser was diagnosed with ovarian cancer in 2009. ...
(Date:1/20/2017)... New York, NY (PRWEB) , ... January 20, ... ... drinks – VW+ 001 and its sugar-free alternative VW+ 002. The drinks have ... the body with optimal conditions to perform during your workout. , After a ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and earnest ... for each of his children. “The Angel” is the creation of published author, Marjorie ... York City, and impassioned writer. , When asked of her new book, Marjorie says, ...
(Date:1/20/2017)... ... ... fine examination of how God handles sin, including how to let go of lingering guilt ... over ten long years has been waiting to release this powerful insight about forgiveness that ... serving the Lord for over twenty years, and he has been preaching and teaching the ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “Christmas in ... creation of published author, Sara Seymour, who lives in Lafayette, Indiana where she works ... sips on iced coffees and writes. , Published by Christian Faith Publishing, Sara Seymour’s ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... James Gilbart , ... 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... recently in a supplement to European Oncology & ... article by James Gilbart and ...
(Date:1/19/2017)... -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the German ... Germany , has purchased a MRIdian ... Clinic Heidelberg as part of its initiative for MRI-based ... be headed by Medical Director and Professor Jürgen Debus, ... German Cancer Research Center (DKFZ), the Heidelberg Heavy Ion ...
(Date:1/19/2017)... PALO ALTO, Calif. , Jan. 19, 2017 /PRNewswire/ ... scientific research, is excited to announce that the ... Project: Cancer Biology  (RP:CB) have been published in ... science, this project represents the first practical evaluation ... that result in reproducible studies. Unlike other assessments ...
Breaking Medicine Technology: